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ABSTRACT
Background. Twelve weeks of renal rehabilitation (RR) have
been shown to improve exercise capacity in patients with
chronic kidney disease (CKD); however, survival following RR
has not been examined.
Methods. This study included a retrospective longitudinal
analysis of clinical service outcomes. Programme completion
and improvement in exercise capacity, characterised as change
in incremental shuttle walk test (ISWT), were analysed with
Kaplan–Meier survival analyses to predict risk of a combined
event including death, cerebrovascular accident, myocardial in-
farction and hospitalisation for heart failure in a cohort of
patients with CKD. Time to combined event was examined
with Kaplan–Meier plots and log rank test between ‘completers’
(attended >50% planned sessions) and ‘non-completers’. In
completers, time to combined event was examined between
‘improvers’ (50m increase ISWT) and ‘non-improvers’
(<50m increase). Differences in time to combined event were
investigated with Cox proportional hazards models (adjusted
for baseline kidney function, body mass index, diabetes, age,
gender, ethnicity, baseline ISWT and smoking status).
Results. In all, 757 patients (male 54%) (242 haemodialysis
patients, 221 kidney transplant recipients, 43 peritoneal dialysis
patients, 251 non-dialysis CKD patients) were referred for RR
between 2005 and 2017. There were 193 events (136 deaths)
during the follow-up period (median 34months). A total of
43% of referrals were classified as ‘completers’, and time to
event was significantly greater when compared with ‘non-com-
pleters’ (P¼ 0.009). Responding to RR was associated with im-
proved event-free survival time (P¼ 0.02) with Kaplan–Meier
analyses and log rank test. On multivariate analysis, completing
RR contributed significantly to the minimal explanatory
model relating clinical variables to the combined event (overall
v2 ¼ 38.0, P< 0.001). ‘Non-completers’ of RR had a 1.6-fold
[hazard ratio¼ 1.6; 95% confidence interval (CI) 1.00–2.58]
greater risk of a combined event (P¼ 0.048). Change in ISWT
of >50m contributed significantly to the minimal explanatory
model relating clinical variables to mortality and morbidity
(overall v2 ¼ 54.0, P< 0.001). ‘Improvers’ had a 40% (hazard
ratio¼ 0.6; 95% CI 0.36–0.98) independent lower risk of a com-
bined event (P¼ 0.041).
Conclusions. There is an association between completion of an
RR programme, and also RR success, and a lower risk of a com-
bined event in this observational study. RR interventions to im-
prove exercise capacity in patients with CKDmay reduce risk of
morbidity and mortality, and a pragmatic randomised con-
trolled intervention trial is warranted.
Keywords: chronic kidney disease, morbidity, mortality, reha-
bilitation, survival
ADDITIONAL CONTENT
An author video to accompany this article is available at:
https://academic.oup.com/ndt/pages/author_videos.
INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of morbidity
and mortality in patients with chronic kidney disease (CKD).
Although many patients with CKD have other risk factors for
CVD (e.g. diabetes, smoking, sedentary lifestyle, hypertension),
and part of the increased risk is attributable to these risk factors,
VC The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA.
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studies demonstrate that CKD itself is a major independent risk
factor [1]. As renal function declines, the association with CVD
increases, and patients with non-dialysis-requiring CKD are
more likely to die from CVD than to develop end-stage renal
disease. There is evidence of an increased prevalence of physical
symptoms associated with declining kidney function [2].
Exercise-based rehabilitation, which promotes a more physi-
cally active lifestyle, has the potential to positively impact upon
functional ability, aerobic capacity and the quality of life of
patients with CKD, independent of the stage of the disease pro-
cess [3–5]. Despite published recommendations calling for
physical activity (PA) and exercise counselling for patients with
CKD [6, 7], exercise-based renal rehabilitation (RR) for patients
with CKD is not routinely offered to patients.
Cardiorespiratory capacity, as measured by the integrated
index of peak oxygen uptake, has been identified as prognosti-
cally important for CVD and all-cause mortality in the general
population [8], and in patients with CKD Stage 5 [9]. Habitual
levels of PA, as measured using self-report questionnaires, are
also linked to CV health. Physical inactivity has been shown to
be a strong independent risk factor for CV morbidity and mor-
tality in patients with CKD Stage 5 [10] and in patients with
CKD Stages 2–4 [11, 12]. Physical inactivity, physical function
limitations, muscle mass and muscle function-related measures
have also been identified as strong predictors of disease progres-
sion and survival in patients at all stages of CKD [2, 13, 14].
Self-reported physical function, as evaluated using the physical
component score from the SF-36 questionnaire, has also been
shown to carry a significant hospitalisation and survival prog-
nostic value for patients on dialysis [15, 16]. To our knowledge,
no studies have compared the survival rates in patients with
CKD who have completed a pragmatic RR exercise-based inter-
vention. A Cochrane review [17], and a systematic review and
research evidence synthesis of studies investigating exercise
therapy for patients with CKD [18], suggest that as the studies
to date have relatively short duration of interventions and
follow-up periods, combined with extremely small sample sizes,
there has been little opportunity thus far for any real observa-
tions with regards to the effect of exercise-based rehabilitation
onmorbidity and mortality rates in patients with CKD.
The King’s College Hospital RR programme for patients with
CKD is a complex exercise-based rehabilitation programme com-
parable in design to the cardiac rehabilitation (CR) [19, 20] and
pulmonary rehabilitation (PR) [21] programmes that are rou-
tinely offered to those patients with disease-specific long-term
conditions in the UK. A systematic review and meta-analysis
showed that those patients after myocardial infarction who
attended CR had a lower risk of all-cause mortality than non-
attendees [22]. A recent study by Houchen-Wolloff et al. [23]
suggested that there was an association between the successful
completion of PR and survival in patients with chronic obstruc-
tive pulmonary disease (COPD), and that PR success [>50m
change in incremental shuttle walk test (ISWT) walking distance]
was associated with improved survival in patients with COPD.
In the interest of evaluating whether the RR programme, of-
fered to patients at all stages of the CKD trajectory at King’s
College Hospital (KCH), was able to offer a comparable event-
free survival advantage when compared with that reported for
PR in the recent study by Houchen-Wolloff et al. [23], we de-
clared the following hypothesis for our study: the successful
completion of a pragmatic RR programme (>50%) for patients
with CKD and RR programme success (>50m change in walk-
ing distance) would be associated with a longer event-free pe-
riod of time in patients with CKD. Our aims, similar to those of
Houchen-Wolloff et al. [23], were to compare the long-term
morbidity and mortality rates in two cohorts of patients re-
ferred to RR: those who successfully completed RR, and a com-
parator group constructed from patients who either did not
complete RR or did not start the programme. Additionally, we
compared survival between those people who were able to
achieve a clinically meaningful improvement in ISWT (>50m
walking distance) following RR with those who were not.
MATERIALS AND METHODS
We conducted a retrospective longitudinal analysis of clinical
service outcomes on all patients with a confirmed diagnosis of
CKD who had been assessed for outpatient-based RR at King’s
College Hospital NHS Trust over a 12-year period from 2005 to
2017. A total of 757 patients (male 54%) from across the CKD
trajectory (242 haemodialysis, 221 kidney transplant recipients,
43 peritoneal dialysis, 251 non-dialysis CKD) had predominately
been referred to the RR service by nephrologists or members of
the renal multidisciplinary team at the hospital. Participants
were included for analysis if they had given their consent for
their data from the RR assessment to be recorded and evaluated
for audit purposes. The only exclusion criteria were missing data
that would preclude ascertaining morbidity or mortality status
for the individual. The study was considered by Camberwell and
St Giles London Research Ethics Committee to be an evaluation
of a clinical service and as such, not requiring ethical approval.
All RR measures recorded were part of the clinical care of
patients referred to the RR service, and were recorded by a
trained health care professional at the initial assessment for RR
and reassessed following completion of the programme.
Maximal exercise capacity was assessed using the ISWT [24].
For the ISWT, the participants were required to walk around
two cones set 9 m apart (so the final track was 10 m) in time to a
set of progressive auditory beeps played on a CD. During exer-
cise testing, resting and post-exercise oxygen saturation and
heart rate were recorded. The test was concluded when the pa-
tient was >0.5m away from the cone when the beep sounded
(allowing one lap to catch up), or if the patient reported that they
were too breathless to continue. The ISWT was performed on at
least two occasions, 30 min apart, at baseline to reduce any learn-
ing effect. Age and gender were recorded together with stage of
CKD, smoking history, height and weight, blood pressure and
diabetes status. The RR programme was modelled on conven-
tional CR, and aimed to deliver an individualised rehabilitation
programme incorporating combined exercise training and self-
management education. The RR programme has been described
previously [3]. Briefly, it is a comprehensive intervention
designed to improve activities of daily living-related functional
capacity, reduce symptoms of fatigue and increase motivation,
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confidence, functional status and health-related quality of life in
patients with CKD. A team consisting of a lead renal physiother-
apist, a specialist physiotherapist and a technical instructor deliv-
ered the exercise, education and self-management advice for the
programme. The patients were required to attend twice-weekly
supervised outpatient exercise and the education sessions, and to
perform once-weekly home-based exercise for a period of
12weeks. Data were collected at the first visit (baseline) and at
12weeks. Following completion of the programme, patients
were advised to continue their home exercise programme but
there were no formal follow-up arrangements.
As our programme has been running for many years, some
patients had been assessed for RR on more than one occasion.
In this event, it was decided to use baseline data relating to the
first completed RR episode, termed the index assessment, to cal-
culate length of follow-up. For patients who had been assessed
more than once but each time had either dropped out of RR or
not started the programme at all, we used baseline data relating
to the first contact with the RR service to calculate length of
follow-up. Mortality status for each identified patient was ascer-
tained by interrogating the hospital renalware database and
electronic patient records between 17 and 24 October 2017. If
patients were event-free to this date, then the number of days
from the date of the index RR assessment to date of censor was
calculated. If patients had experienced an event [death, cerebro-
vascular accident (confirmed stroke), myocardial infarction and
hospitalisation for heart failure], then the number of days from
date of the index assessment to date of event was calculated.
Patients were classified as having completed a course of RR
if they completed the post-RR assessment. The data set was rig-
orously checked for duplicates to ensure that no patient was
classified as both having completed a course of RR and also as a
non-completer. For those patients who completed RR, we fur-
ther subdivided people into those who were classified as having
successfully ‘improved’ in exercise capacity by achieving a
change in ISWT distance of 50m or more following RR
(rounded up from the value of the minimal clinically important
difference) of the ISWT recorded for patients completing a PR
programme¼ 47.5m) or as a ‘non-improver’ in exercise capac-
ity if the change in ISWTwas<50m [25].
Baseline differences were compared between those patients
who completed RR and ‘non-completers’, as well as between
‘improvers’ and ‘non-improvers’ to exercise training using inde-
pendent t-tests for continuous variables, while Chi-square tests
were used to compare categorical variables. Event-free time
was compared for ‘completers’ and ‘non-completers’ and
‘improvers’ and ‘non-improvers’ graphically using Kaplan–
Meier survival analysis. Differences in time to combined event in
both groups were analysed with the use of the log rank test. Cox
regression analysis was used to generate regression b coefficients
(B) for a range of baseline variables (age at assessment, gender,
ethnicity, smoking status, diabetes, modality and pre-RR ISWT
distance) to determine factors that independently predicted the
risk of a combined event. The model was run twice, firstly to in-
clude the effect of completion of rehabilitation on survival and
secondly to include the value of metre change in ISWT for those
patients classified as ‘completers’. Continuous variables are pre-
sented as mean (SD) unless otherwise stated. A P < 0.05 was
considered to be statistically significant in all analyses. Analysis
was carried out using Predictive Analytics Software Statistics ver-
sion 18 (formerly SPSS, IBMCorporation, Armonk, NY, USA).
RESULTS
Morbidity and mortality status were ascertained for 757 patients
(male 54%) from across the CKD trajectory (242 haemodialysis
patients, 221 kidney transplant recipients, 43 peritoneal dialysis
patients, 251 non-dialysis CKD patients) who were referred for
RR over a 12-year period from 2005 to 2017 and fulfilled the in-
clusion/exclusion criteria. There were 193 events, including 136
deaths during the follow-up period (median follow-up of
34months). Table 1 presents demographic data and baseline
measures for all patients at the time of the index assessment.
Patients were predominately haemodialysis, non-dialysis CKD
or kidney transplant recipients. An assessment on completion of
a course of RR was ascertained for 43% of the patients in the co-
hort while data were available for 57% patients who did not start
or dropped out of rehabilitation and did not go on to complete a
further course of RR. Table 2 shows a comparison of the varia-
bles at the index assessment between those patients who com-
pleted a full course of RR and those who did not start or dropped
out. Patients who did not complete RR were found to be younger
(55 years versus 58 years, P¼ 0.001) than ‘completers’, more
likely to be from a black andminority ethnic origin (n¼ 293 ver-
sus n¼ 172, P¼ 0.027), receiving haemodialysis therapy
(n¼ 169 versus n¼ 80, P¼ 0.001) or to have received a kidney
transplant (n¼ 121 versus n¼ 89, P¼ 0.027), and to have a
lower baseline ISWT distance (261m versus 296m, P< 0.001).
Figure 1 presents the Kaplan–Meier survival analysis for
‘completers’ and ‘non-completers’ of RR. A statistically signifi-
cant difference was found between the two groups (log rank
test, P¼ 0.009). Cox regression was used to determine which
factors independently predicted time to the combined event.
Factors used in the model were baseline age, smoking status,
gender, ethnicity, diabetes, body mass index (BMI), modality,
Table 1. Patient demographics at baseline RR assessment
Mean (SD) unless otherwise stated n¼ 757
Age at assessment (years) 56.11 (12.38)
Gender (male/female) (%) 54/46
Modality
Non-dialysis CKD (%) 251 (33)
Haemodialysis (%) 242 (32)
Peritoneal dialysis (%) 43 (6)
Kidney transplant (%) 221 (29)
Ethnicity
Black British/African/Caribbean (%) 429 (55.6)
Asian (%) 86 (11.0)
White Caucasian (%) 242 (31.2)
eGFR (mL/min/1.73 m2) 30.32 (26.65)
Smoker (yes/no) (%) 86/14
Diabetes (yes/no) (%) 59/41
BMI (kg/m2) 30.79 (7.00)
ISWT distance (m) 289.92 (170.69)
eGFR, estimated glomerular filtration rate.
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baseline ISWT and completion of RR (Table 3). Onmultivariate
analysis, completing an RR programme contributed signifi-
cantly to the minimal explanatory model relating clinical varia-
bles to mortality and CV morbidity (overall v2 ¼ 38.0,
P< 0.001). Patients who did not complete the RR programme
had a 1.6-fold independent greater risk of a combined event
[hazard ratio¼ 1.6; 95% confidence interval (95% CI) 1.00–
2.58; P¼ 0.048]. Other factors found to independently predict a
longer event-free period were higher baseline ISWT distance
(P¼ 0.016), not having diabetes (P¼ 0.05) and younger age at
assessment (P¼ 0.002). Gender, modality, ethnicity, smoking
status and BMI did not independently predict a longer period
of time to event.
Of the 335 patients who completed rehabilitation, an in-
crease of 50m in the ISWT was found in 60% (n¼ 200) of the
patients, classified as successful ‘improvers’ in exercise capacity.
Figure 2 presents the survival analysis between the ‘improvers’
and ‘non-improvers’ in exercise capacity, and a statistically
Table 2. Baseline variables for those patients who completed and did not complete RR
Baseline mean (SD) unless otherwise stated Completed RR, n¼ 335 (44.3%) Did not complete RR, n¼ 422 (55.7%) P-value
Age at assessment (years) 58.44 (11.90) 54.96 (11.32) <0.001
Men, n (%) 184 (56.1) 226 (53.9) NS
Women, n (%) 151 (43.9) 196 (46.1) NS
Modality <0.001
Non-dialysis CKD (%) 138 (44.2) 101 (23.8)
Haemodialysis (%) 80 (24.4) 169 (40.5)
Peritoneal dialysis (%) 28 (4.8) 31 (6.8)
Kidney transplant (%) 89 (26.6) 121 (28.6)
Ethnicity 0.027
Black British/African/Caribbean (%) 147 (52.9) 244 (57.8)
Asian (%) 25 (9.0) 49 (11.6)
White Caucasian (%) 102 (36.7) 117 (27.7)
BMI (kg/m2) 31.32 (6.33) 30.71 (6.00) NS
eGFR for all modalities (mL/min/1.73 m2) 32.96 (28.32) 27.93 (26.16) NS
eGFR non-dialysis CKD 40.43 (31.04) 37.47 (29.07)
eGFR kidney transplant 45.77 (22.64) 47.62 (24.73)
Diabetes (yes/no) (%) 35.1/64.9 44.7/55.3 0.013
Hypertension (yes/no) (%) 82.9/17.1 82.0/18.0 NS
Smoker (yes/no) (%) 12.9/87.1 12/1/87.9 NS
ISWT (m) 295.68 (162.43) 260.67 (157.57) <0.001
eGFR, estimated glomerular filtration rate; NS, non-significant.
FIGURE 1: Kaplan–Meier survival analysis for ‘completers’ and ‘non-completers’ of RR.
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significant difference in survival time was found between the
groups (log rank test, P¼ 0.02). For those people who com-
pleted RR, a second Cox regression model was run using the
same factors as described previously, but substituting magni-
tude of change in ISWT distance instead of completion of RR in
the model (Table 4). Change in ISWT of >50m contributed
significantly to the minimal explanatory model relating clinical
variables to mortality and CV morbidity (overall v2 ¼ 54.0,
P< 0.001). ‘Improvers’ had a 40% independent lower risk of a
combined event (hazard ratio¼ 0.6; 95% CI 0.36–0.98;
P¼ 0.04). A higher baseline ISWT distance (P¼ 0.001) and
younger age (P¼ 0.019) also predicted a longer event-free pe-
riod of time.
DISCUSSION
This study examined the effect of completing an exercise-based
RR programme, and also the success in the programme, on the
time to the combined outcome of all-cause mortality and CV
morbidity in a population of patients with all stages of CKD.
There is strong evidence that patients who completed the pro-
gramme were significantly more likely to have a longer com-
bined event-free period than those who did not complete the
programme, along with better baseline exercise capacity (ISWT
walking distance), absence of diabetes and younger age. There
was also strong evidence that patients who improved their exer-
cise capacity as a result of the exercise programme (achieved a
walking distance of >50m in the ISWT) also were significantly
more likely to have a longer combined event-free period than
those who did not improve their exercise capacity, along with
better baseline exercise capacity and younger age. To our
knowledge, this is the first study to report on the association be-
tween participation in a disease-specific RR programme and the
combined outcome of mortality and CV morbidity in patients
with CKD.
The results from our study are in agreement with the results
from the study by Houchen-Wolloff et al. [23], which reported
that patients with COPD who successfully completed a course
of PR had a statistically significant survival advantage compared
with those patients who dropped out of the programme or
failed to start in the first place. The results from our current
Table 3. Results of Cox regression analysis to identify factors that indepen-
dently predict event-free survival time, including completion of an RR
programme
Variable B Exponential
(95% CI) for B
P-value
Non-completion of RR 0.476 1.609 (1.004–2.580) 0.048
Gender 0.300 0.741 (0.462–1.118) 0.213
Smoker 0.399 0.671 (0.325–1.384 0.280
BMI 0.043 0.958 (0.915–1.003) 0.069
Diabetes 0.512 0.599 (0.359–1.001) 0.050
ISWT (pre-RR) 0.002 0.998 (0.996–1.000) 0.016
Non-dialysis CKD 0.207 1.231 (0.637–2.376) 0.537
Haemodialysis 0.370 0.964 (0.553–1.681) 0.686
Peritoneal dialysis 0.551 0.576 (0.195–1.705) 0.319
Kidney transplant 0.277 0.758 (0.375–1.532) 0.440
Ethnicity
Black British/African/Caribbean 1.005 2.731 (0.885–8.427) 0.081
Asian 0.221 1.248 (0.751–2.074) 0.393
White Caucasian 0.280 0.756 (0.352–1.627) 0.472
FIGURE 2: Kaplan–Meier survival analysis for ‘improvers’ and ‘non-improvers’ in exercise capacity.
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study similarly demonstrated a significantly longer event-free
survival period between those patients who improved by 50m
(or greater) in the ISWT and those who did not. The results
suggest that participation in a disease-specific exercise-based re-
habilitation programme may be as beneficial for patients with
CKD as it is for those patients with COPD who participate in a
PR programme [23].
The results of this current study suggest that there is a longer
event-free survival period for patients with CKD who complete
an RR programme. The RR programme is a complex interven-
tion that is designed to ‘kick-start’ a healthy lifestyle change for
patients with CKD. In addition to individualised exercise pre-
scription, there is also a behavioural change and educational
component to the programme. The educational component
includes discussions on healthy eating, medication usage, living
with a long-term condition, self-efficacy for exercise behaviour
and increasing and maintaining motivation with PA [3]. It may
be suggested that it is this holistic approach that will have con-
tributed to the CV protective effect of completing an RR pro-
gramme. Our group previously demonstrated that participation
in a weight loss programme, which utilised a combination of a
low-fat, energy-reduced renal diet, regular exercise, the use of
the anti-obesity medication Orlistat (120mg three times daily,
Xenical; Roche Products, Basel, Switzerland) and behavioural
therapy techniques to address barriers to lifestyle change, was
associated with a longer event-free survival period in patients
with CKD, rather than just weight loss alone [26]. The authors
concluded that changes in eating habits and PA may have pro-
vided greater CV protection than weight loss alone. Our current
study supports this hypothesis as we demonstrated that the
event-free survival period increased with an improvement in
ISWTwalking distance. This strongly suggests that an improve-
ment in exercise capacity is a key protective factor against CV
morbidity and mortality in patients who complete an RR pro-
gramme, and supports the evidence demonstrating a link be-
tween improved cardio-respiratory fitness, CVD health and
survival in patients with CKD [9, 10, 27].
There has been much controversy in recent years around the
effectiveness of the pragmatic delivery of exercise-based rehabil-
itation, when compared with research-specific interventions.
This has been particularly pertinent in CR [28, 29]. The 2016
Cochrane review and meta-analysis of randomised controlled
trials of CR reported a lack of reduction in mortality [22], in
comparison with the previous 2011 review, which reported a re-
duction in overall mortality, absolute risk reduction, number
needed to treat, as well as CVmortality. The inclusion of a prag-
matic UK CR trial has been cited as the main reason for this
lack of effect on mortality [30]. It would appear reasonable to
speculate that the overall dose of exercise prescribed in the
pragmatic study was not sufficient or effective in favourably
modifying CV risk factors, and thus event-free survival. It is im-
perative, especially considering the associated link between im-
proved exercise capacity and event-free survival suggested by
the results of our current study, that any future pragmatic RR
studies aim to accurately quantify and prescribe exercise dosage
to improve exercise capacity.
The major limitation of the analysis is the unmeasured con-
founding, namely that patients who are most motivated to com-
plete an RR course are more motivated to look after themselves,
and will therefore live longer. Likewise, patients who have man-
aged to increase their ISWT could be those who are more physi-
cally fit, and will therefore live longer. Although we have
included these variables in our multivariable risk model, it
remains impossible to fully adjust for these confounders with-
out conducting a randomised controlled clinical trial. An addi-
tional limitation is that this study is an observation of outcomes
of clinical practice. As in the study by Houchen-Wolloff et al.
[23], we constructed two comparative groups: one made up of
people who, for whatever reason, failed to complete RR (or did
not start the programme) and the other made up of people who
had completed a course of RR. In cases where multiple courses
of RR were completed by a single patient, we chose the first
complete episode over any subsequent episodes. Although the
exercise training offered in the RR classes was encouraged at a
moderate level of intensity (modulated with the rate of per-
ceived exertion RPE scoring measure and heart rate monitors),
this was not recorded for individual participants. A future rand-
omised controlled trial (RCT) would collect data on the average
intensity and duration of exercise sessions and also question
whether those participants who exercise at higher intensities, or
for longer durations, have fewer events. It is also acknowledged
that survival of someone assessed in 2005 may be different from
those assessed in 2017 due to advances in the field, and changes
in medical treatment. This current study does not report statin
usage or albuminuria, which has been found to contribute to
mortality risk in patients with CKD [31, 32]. The current study
also does not include blood pressure data. Although this was
collected as a clinical measure to inform patient safety for exer-
cise training, it was not collected in research conditions.
It is also acknowledged that, in a similar way to the study
by Houchen-Wolloff et al. [23], we have ‘missed’ a group of
patients: those who were unwilling to even be referred for re-
habilitation. Event-free survival time in these patients is un-
known due to study selection bias. There are a number of
Table 4. Results of Cox regression analysis to identify factors that indepen-
dently predict event-free survival time, including magnitude of change in
exercise capacity (DISWT), for patients who completed RR
Variable B Exponential
(95% CI) for B
P-value
DISWT (pre- to post-RR) 0.522 0.593 (0.360–0.970) 0.041
Age at assessment 0.020 1.020 (1.003–1.038) 0.019
Gender 0.322 0.718 (0.466–1.105) 0.132
Smoker 0.396 0.673 (0.341–1.329) 0.254
BMI 0.006 0.994 (0.982–0.999) 0.313
Diabetes 0.463 0.629 (0.399–0.991) 0.053
ISWT (pre-RR) 0.003 0.997 (0.997–0.999) 0.001
Non-dialysis CKD 0.165 1.179 (0.614–2.264) 0.620
Haemodialysis 1.303 1.353 (0.827–2.216) 0.229
Peritoneal dialysis 0.229 0.795 (0.338–1.872) 0.600
Kidney transplant 0.242 0.785 (0.338–1.872) 0.600
Ethnicity
Black British/African/Caribbean 0.400 1.492 (0.395–3.741) 0.393
Asian 0.019 1.019 (0.656–1.584) 0.932
White Caucasian 0.507 0.602 (0.305–1.189) 0.144
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additional factors that may have confounded results, and are
similar to those cited in our previous work [26]. These include
factors such as ability for patients to travel to the hospital to
take part in the in-centre RR programme, social support,
socio-economic status, literacy and education level. As our
study was conducted in a single centre, the results may also
not be generalisable to the wider population of patients with
CKD. A randomised controlled trial, where all these factors
are equal across groups, would be required to fully elucidate
whether the relationship we have found in our current study
is due to an unmeasured variable, such as motivation to in-
crease exercise and PA levels.
Completion of an RR programme was associated with a lon-
ger event-free survival period in our study population. In addi-
tion, RR success (>50m increase in ISWT distance) was
associated with a lower risk of a combined event. RR interven-
tions to improve exercise capacity in patients with CKD may re-
duce the combined risk of CV morbidity and mortality, and a
pragmatic randomised controlled intervention trial is warranted.
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ABSTRACT
Background. Chronic kidney disease (CKD) is associated with
poor mobility. Peripheral nerve function alterations play a sig-
nificant role in low mobility. We tested the hypothesis that early
CKD is associated with altered sensory, motor and autonomic
nerve function.
Methods. Participants in the Health, Aging and Body
Composition cohort who had kidney function measures in Year
3 (1999–2000) and nerve function measurements at Year 4
(2000–01) were analyzed (n¼ 2290). Sensory (vibration thresh-
old, monofilament insensitivity to light and standard touch),
motor [compound motor action potentials (CMAPs), nerve
conduction velocities (NCVs)] and autonomic (heart rate re-
sponse and recovery after a 400-m walk test) nerve function as
well as participant characteristics were compared across cystatin
C- and creatinine-based estimated glomerular filtration rate cat-
egorized as60 (CKD) or>60mL/min/1.73m2 (non-CKD).
VC The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. 625
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